LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Vitamin D Insufficiency Linked to Development of Crohn's Disease

By LabMedica International staff writers
Posted on 09 Feb 2010
Results published in a recent paper suggest that supplementing the diet with vitamin D can protect against development of Crohn's disease, a chronic incurable inflammatory bowel condition.

Vitamin D signaling through the vitamin D receptor has emerged as a key regulator of innate immunity in humans. Investigators at McGill University (Montreal, Canada) extended this observation to the serious autoimmune syndrome known as Crohn's disease.

They reported in the January 22, 2010, edition of the Journal of Biological Chemistry that vitamin D acted directly to stimulate two genes that could be related to the development of Crohn's disease. The first, the beta defensin 2 gene, encodes an antimicrobial peptide that interacts with intestinal bacteria. The second, the NOD2 gene, alerts immune cells to the presence of invading microbes. When vitamin D levels were insufficient, these two genes malfunctioned, which induced the type of inflammatory response found in Crohn's disease.

"Our data suggests, for the first time, that vitamin D deficiency can contribute to Crohn's disease," said Dr. John White, professor of physiology at McGill University. "It is a defect in innate immune handling of intestinal bacteria that leads to an inflammatory response that may lead to an autoimmune condition."

"Siblings of patients with Crohn's disease that have not yet developed the disease might be well advised to make sure they are vitamin D sufficient," said Dr. White. "It is something that is easy to do, because they can simply go to a pharmacy and buy vitamin D supplements. The vast majority of people would be candidates for vitamin D treatment."

Related Links:

McGill University


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Rapid Molecular Testing Device
FlashDetect Flash10

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more